Global Biobanking Equipment Market Overview And Scope:
Global Biobanking Equipment Market Size was estimated at USD 165.12 million in 2022 and is projected to reach USD 203.38 million by 2028, exhibiting a CAGR of 3.53% during the forecast period.
The Global Biobanking Equipment Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Biobanking Equipment utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
Top Key Players Mentioned Are: Thermo Fisher, Qiagen N.V., Hamilton, Brooks Automation, Worthington Industries, BD, Merck, Micronic
Global Biobanking Equipment Market Segmentation
By Type, Biobanking Equipment market has been segmented into:Blood Products
Human Tissues
Cell Lines
Nucleic Acids
By Application, Biobanking Equipment market has been segmented into:
Regenerative Medicine
Life Science
Clinical Research
Regional Analysis:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biobanking Equipment market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biobanking Equipment market.
Top Key Players Covered in Biobanking Equipment market are:
Thermo Fisher
Qiagen N.V.
Hamilton
Brooks Automation
Worthington Industries
BD
Merck
Micronic
Objective to buy this Report:
1. Biobanking Equipment analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Biobanking Equipment market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Biobanking Equipment Market by Type
5.1 Biobanking Equipment Market Overview Snapshot and Growth Engine
5.2 Biobanking Equipment Market Overview
5.3 Blood Products
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Blood Products: Geographic Segmentation
5.4 Human Tissues
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Human Tissues: Geographic Segmentation
5.5 Cell Lines
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Cell Lines: Geographic Segmentation
5.6 Nucleic Acids
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2017-2032F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Nucleic Acids: Geographic Segmentation
Chapter 6: Biobanking Equipment Market by Application
6.1 Biobanking Equipment Market Overview Snapshot and Growth Engine
6.2 Biobanking Equipment Market Overview
6.3 Regenerative Medicine
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Regenerative Medicine: Geographic Segmentation
6.4 Life Science
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Life Science: Geographic Segmentation
6.5 Clinical Research
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Clinical Research: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Biobanking Equipment Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Biobanking Equipment Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Biobanking Equipment Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 THERMO FISHER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 QIAGEN N.V.
7.4 HAMILTON
7.5 BROOKS AUTOMATION
7.6 WORTHINGTON INDUSTRIES
7.7 BD
7.8 MERCK
7.9 MICRONIC
Chapter 8: Global Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Blood Products
8.2.2 Human Tissues
8.2.3 Cell Lines
8.2.4 Nucleic Acids
8.3 Historic and Forecasted Market Size By Application
8.3.1 Regenerative Medicine
8.3.2 Life Science
8.3.3 Clinical Research
Chapter 9: North America Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Blood Products
9.4.2 Human Tissues
9.4.3 Cell Lines
9.4.4 Nucleic Acids
9.5 Historic and Forecasted Market Size By Application
9.5.1 Regenerative Medicine
9.5.2 Life Science
9.5.3 Clinical Research
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Blood Products
10.4.2 Human Tissues
10.4.3 Cell Lines
10.4.4 Nucleic Acids
10.5 Historic and Forecasted Market Size By Application
10.5.1 Regenerative Medicine
10.5.2 Life Science
10.5.3 Clinical Research
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Blood Products
11.4.2 Human Tissues
11.4.3 Cell Lines
11.4.4 Nucleic Acids
11.5 Historic and Forecasted Market Size By Application
11.5.1 Regenerative Medicine
11.5.2 Life Science
11.5.3 Clinical Research
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Blood Products
12.4.2 Human Tissues
12.4.3 Cell Lines
12.4.4 Nucleic Acids
12.5 Historic and Forecasted Market Size By Application
12.5.1 Regenerative Medicine
12.5.2 Life Science
12.5.3 Clinical Research
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Blood Products
13.4.2 Human Tissues
13.4.3 Cell Lines
13.4.4 Nucleic Acids
13.5 Historic and Forecasted Market Size By Application
13.5.1 Regenerative Medicine
13.5.2 Life Science
13.5.3 Clinical Research
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Biobanking Equipment Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Blood Products
14.4.2 Human Tissues
14.4.3 Cell Lines
14.4.4 Nucleic Acids
14.5 Historic and Forecasted Market Size By Application
14.5.1 Regenerative Medicine
14.5.2 Life Science
14.5.3 Clinical Research
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Biobanking Equipment Scope:
|
Report Data
|
Biobanking Equipment Market
|
|
Biobanking Equipment Market Size in 2025
|
USD XX million
|
|
Biobanking Equipment CAGR 2025 - 2032
|
XX%
|
|
Biobanking Equipment Base Year
|
2024
|
|
Biobanking Equipment Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher, Qiagen N.V., Hamilton, Brooks Automation, Worthington Industries, BD, Merck, Micronic.
|
|
Key Segments
|
By Type
Blood Products
Human Tissues
Cell Lines
Nucleic Acids
By Applications
Regenerative Medicine
Life Science
Clinical Research
|
